Neuronal inhibitory mechanisms in overweight/obesity and food/eating addiction: The role of frontal brain coherence, dysregulated eating, and depressive symptoms
Journal of Behavioral Addictions · 15.07.2026 · 15 (2) · 915-920
DOI: 10.1556/2006.2025.00344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Behavioral Addictions, erschienen am 15.07.2026. Verfasst von Roni Aviram-Friedman und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Nutrition Sciences, Faculty of Health Sciences, Ariel University, Ariel, 40700, Israel. Hauptthemen laut MEDLINE: Food Addiction, Obesity, Depression, Prefrontal Cortex. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Israel Science Foundation.
Themen: Depression, Sucht und Abhängigkeit
Abstract (Originalsprache)
Background and aims Obesity and food/eating addiction are associated with deficits in inhibitory control mechanisms manifested in the lateral prefrontal cortex (LPFC) bilaterally. We explored abnormalities in the functional coherence between the hemispheres and within each of them.
Methods
Resting-state electroencephalography (EEG) was utilized to examine intra- and inter-hemispheric frontal brain coherence in individuals with obesity and food/eating addiction (FAOB, n = 27), those with obesity without addiction (Non-FAOB, n = 11), and healthy controls (HC, n = 15). Participants were included in this study following assessment of their BMI and Yale Food Addiction Scale (YFAS) scores. In addition, depressive symptoms were measured with the Beck Depression Inventory (BDI).
Results
Individuals with obesity (FAOB and Non-FAOB combined) exhibited higher interhemispheric frontal (IF) and right frontal (RF) coherence compared to healthy controls. Within the obesity group, Non-FAOB participants showed higher IF and RF coherence than the FAOB group. These results remained significant after controlling for BDI scores. Depressive symptoms in the FAOB group were higher than those of the HC group.
Discussion
Elevated frontal coherence, both between the frontal hemispheres and within the right frontal hemisphere, may be associated with effortful cognitive control and possibly a compensatory neurocognitive correlate associated with differential susceptibility to developing addictive-like overeating.
Conclusions
Frontal brain coherence patterns represent candidate neurophysiological correlates of differential vulnerability to addictive-like overeating in individuals with overweight/obesity and warrant longitudinal investigation to establish their prognostic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1Department of Nutrition Sciences, Faculty of Health Sciences, Ariel University, Ariel, 40700, Israel.
- 2Department of Life Sciences and the Zelman Center for Brain Science Research, Ben-Gurion University, Be'er Sheva, 84105, Israel.
Förderung
- Israel Science Foundation
Zitieren
APA
Aviram-Friedman, R., Baz, G., Kafri, L., Alyagon, U., & Zangen, A. (2026). Neuronal inhibitory mechanisms in overweight/obesity and food/eating addiction: The role of frontal brain coherence, dysregulated eating, and depressive symptoms. Journal of Behavioral Addictions, 15(2), 915-920. https://doi.org/10.1556/2006.2025.00344
Vancouver
Aviram-Friedman R, Baz G, Kafri L, Alyagon U, Zangen A. Neuronal inhibitory mechanisms in overweight/obesity and food/eating addiction: The role of frontal brain coherence, dysregulated eating, and depressive symptoms. Journal of Behavioral Addictions. 2026;15(2):915-920. doi:10.1556/2006.2025.00344
BibTeX
@article{AviramFriedman2026,
author = {Aviram-Friedman, Roni and Baz, Guy and Kafri, Lior and Alyagon, Uri and Zangen, Abraham},
title = {Neuronal inhibitory mechanisms in overweight/obesity and food/eating addiction: The role of frontal brain coherence, dysregulated eating, and depressive symptoms},
journal = {Journal of Behavioral Addictions},
year = {2026},
volume = {15},
number = {2},
pages = {915--920},
doi = {10.1556/2006.2025.00344}
}
EUVIMED